Point-of-Care Ultrasound (POCUS) Findings and Impact on Vaping
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Mar 21, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the effects of vaping on lung health in adolescents. Researchers want to see if using a special ultrasound technique can help identify any early lung problems in young people who vape. They also hope that showing these ultrasound results to the participants will encourage them to change their attitudes towards vaping and possibly quit. This study is important because vaping has become a common issue among teenagers, and many believe it is safer than smoking traditional cigarettes, even though it can still harm their lungs.
To participate, candidates must be between 12 and 18 years old, have their own cell phone or email, and be part of a group that includes both vapers and non-vapers. Participants will undergo a lung ultrasound, which is a safe procedure that uses sound waves to create images of the lungs. They will also have the chance to discuss their results with the researchers. However, some individuals, such as those with chronic lung conditions or recent respiratory infections, may not be eligible to join the study to ensure their safety. This research aims to provide valuable insights into vaping's impact on health and potentially help young people make healthier choices.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 12-18 years of age
- • Has own individual cell phone or email for communication
- • Member of a vaping history group that is not yet full for enrollment (ex: up to 100 vapers, up to 100 non-vapers)
- • Able to speak and understand English
- Exclusion Criteria:
- • Chronic Lung Disease
- • History of pneumothorax
- • Prior thoracic surgery including VATS (Video-assisted thoracoscopic surgery)
- • Sickle cell disease
- • Current or prior cancer
- • Significant congenital heart disease
- • Acute upper respiratory infection (cough or congestion in the last 3 days)
- • Acute chest trauma
- • Acute pulmonary embolism
- • Sedation medication administered prior to study image acquisition
- • Known allergy or sensitivity to ultrasound gel
- • Significant acute psychosis, mania, or suicidal ideation
- • Any other medical or psychiatric condition or other significant concern that in the investigator's opinion would impact participant safety or compliance with study instructions, or potentially confound the interpretation of findings
- • Inability or unwillingness of subject or legal guardian/representative to give informed consent/assent.
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported